Products for Research Use Only

Ozuriftamab vedotin

CAT: 0804-HY-145627-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-145627-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ozuriftamab vedotin (BA3021), an antibody-drug conjugate (ADC), is a conditionally active biologic (CAB) anti-receptor tyrosine kinase orphan receptor 2 (ROR2) humanized monoclonal antibody Ozuriftamab conjugated to VcMMAE (HY-15575). Ozuriftamab vedotin has antitumor activities[1].
CAS Number
2460400-11-5
Product Name Alternative
BA3021; Anti-ROR2 ADC; CAB-ROR2-ADC
UNSPSC
12352211
Target
Antibody-Drug Conjugates (ADCs) ; Microtubule/Tubulin
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ozuriftamab-vedotin.html
Purity
99.65
Smiles
[Ozuriftamabvedotin]
References & Citations
[1]Alan L. Ho, et al. Abstract PO-007: A phase 2 open-label study of conditionally active biologic, ozuriftamab vedotin (BA3021) in PD-1/L1 failure patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2023) 29 (18_Supplement) : PO-007.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
Reference compound1
Clinical Information
Phase 2